IDEAYA Biosciences (IDYA) Operating Margin Growth (5y) (2025 - 2026)

IDEAYA Biosciences (IDYA) Operating Margin Growth (5y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,102.16 Bn	67,101.87 Bn	-
2	Nanobiotix	1,908.96 Bn	1,908.90 Bn	-
3	Akari Therapeutics	959.56 Bn	959.56 Bn	-
4	BeOne Medicines	474.03 Bn	469.24 Bn	1.35 Bn
5	Vertex Pharmaceuticals	122.13 Bn	114.88 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.09 Bn	61.34 Bn	3.31 Bn
7	Belite Bio	62.34 Bn	62.34 Bn	-
8	Argenx Se	55.96 Bn	50.77 Bn	1.41 Bn
9	Alnylam Pharmaceuticals	37.53 Bn	34.52 Bn	959.66 Mn
10	IDEAYA Biosciences	3.20 Bn	2.53 Bn	-

Download Data